Aurobindo Pharma to acquire Lannett Company for $250m.

Synopsis

Aurobindo Pharma, a leading integrated global pharmaceutical company, agreed to acquire Lannett Company, a US-based pharmaceutical manufacturer and supplier specializing in complex generics, for $250m.

Principals

target

Lannett Company

bidder

Aurobindo Pharma

Show Details & Financials

Did you work on this deal?

Claim Deal

Showcase your expertise to over 3 million dealmakers and industry leaders on Datasite.

Claim Deal

Market Context

MergerLinks - Aurobindo Pharma to acquire Lannett Company for $250m.